Niels Engberding is a Cardiology physician. OpenAlex indexes 31 publications with 1,183 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 Jackson St
Denver, CO 802062761
Telephone
303-388-4461Provider last certified this registry record 12 Apr 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.8%Beta blocker17.4%Metoprolol Succinate54%Carvedilol23%Metoprolol Tartrate20%Atenolol3%Part D<11 patientsStatin15.1%Atorvastatin Calcium68%Rosuvastatin Calcium19%Pravastatin Sodium9%Simvastatin5%Part D<11 patients+ 13 more classes in this area
Blood & clotting
15.9%Direct thrombin inhibitors8.6%Pradaxa91%Dabigatran Etexilate9%Part D≥94 patientsFactor Xa inhibitor3.7%Eliquis89%Xarelto11%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
7.2%SGLT2 inhibitor3.2%Jardiance100%Part D≥30 patientsPotassium supplement2.5%Potassium Chloride100%Part D≥39 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Faculty Opinions recommendation of Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
2017 - Faculty Opinions recommendation of Contemporary Trends and Age-Specific Sex Differences in Management and Outcome for Patients With ST-Segment Elevation Myocardial Infarction.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
2017 - Faculty Opinions recommendation of Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”